Biocitech And The Seine-Saint-Denis Chamber Of Commerce And Industry (CCI) Introduce The Winners Of The First Biocitech Funding Day
Opening with a speech by Claude Bartolone, chairman of France’s National Assembly, the event dedicated to funding healthcare and biotechnology businesses welcomed 300 people to BIOCITECH
The winning businesses in the pitching competition are PHYCOPHARMA, KALLISTEM and HPE INGREDIENTS
Romainville, France, June 26, 2015 – BIOCITECH, the city complex for healthcare and biotechnology businesses and the Seine-Saint-Denis Chamber of Commerce and Industry (CCI), today announce the three winners of the first BIOCITECH Funding Day. Taking place in BIOCITECH’s fully refurbished auditorium, this one-day event for start-ups and SMEs in the healthcare and biotechnology sector is a chance for entrepreneurs, leading players in funding and sector experts to engage in discussion and debate.
The winners of the pitching competition were announced during the evening and prizes were awarded by the Bibliothèque nationale de France (BnF), Crescentia consulting, EY, Granrut and La Simple Agence. To begin with, 25 of the businesses that registered on the website were selected to make a poster presentation of their business to investors. Nine of them were given the opportunity to pitch at a plenary session. To conclude the day, a panel made up of members from each round-table session selected three winners:
• Phycopharma: development prize, creates drug candidates based on microalgae for the treatment of resistant tumors
• Kallistem: seed-funding prize, develops innovative cell culture technology in reproductive biology
• HPE Ingredients: emergence prize, aims to develop nutrition and heath ingredients from food processing of snails.
The winners will benefit from:
• Project evaluations carried out by Ernst & Young
• Legal counsel (corporate, social and fiscal law, IP-IT) by Granrut
• Business development consulting by Crescentia
• Communication advice with La Simple Agence
• Free access to and use of a prestigious room at the BnF for a business event
Organized by BIOCITECH and the Seine-Saint-Denis CCI, the event aims to clarify the expectations of businesses from financial backers and vice versa, ensuring a shared understanding of the keys to funding. It also provides insight into the funding hurdles that healthcare and biotechnology businesses can face at every stage of their lifecycle, including:
• Funding for the growth of mature businesses
• Funding for initial phases of development
• Seed funding
The inaugural event featured speeches from political figures such as Claude Bartolone and from players in innovation and funding for innovation, such as Christian Lajoux, chairman of the Medicen Paris Region healthcare competitiveness cluster. There were also presentations from BIOCITECH resident companies, including Galapagos and Pherecydes Pharma; on their experience of funding, from fundraising to crowdfunding and stock market listing.
“Businesses in the healthcare and biotechnology sector offer a rich seam of growth and employment opportunities. Biocitech residents are no exception,” said Pierre-Antoine Gailly, chairman of the CCI for the Paris-Ile-de-France region. “Many of them need access to significant ongoing funding, in view of the high levels of risk and the lengthy development time associated with the sector. These businesses now have to muster considerable energy and resources for their fundraising to be successful. This event gives them the chance to meet a large number of potential investors in just one day.”
“We are very pleased with the success of this first BIOCITECH Funding Day, organized jointly with our partner, the CCI for Seine-Saint-Denis. The event was a tremendous opportunity for our resident businesses and for the other businesses present to meet and engage in dialogue with the leading players in funding. Dialogue and round-table discussions focused on the keys to successful fundraising and the secrets of funding for growth,” said Jean-François Boussard, chairman of BIOCITECH. “We will continue to organize this kind of event at the BIOCITECH city complex as it fits perfectly with our purpose; supporting our residents in their development and growth. Please join the discussion on the blog. I look forward to seeing you next year, for the second BIOCITECH Funding Day.”
“I wanted to take part in this first BIOCITECH Funding Day as the new chairman of Medicen, since we are working to enhance the appeal of the Ile-de-France region and the vitality of the healthcare sector, reflecting the vitality of the BIOCITECH city complex. This kind of event helps to provide players in the healthcare sector with the keys to funding and gives them access to expert advice to accelerate their development,” added Christian Lajoux, chairman of Medicen Paris Region.
In the life sciences sector, the Ile-de-France has a concentration of 300 public and private sector research laboratories, 11,800 researchers, including 4,400 in industry, and prestigious, world-renowned organizations such as the Institut Pasteur, the Institut Curie, the Institut Gustave Roussy, the French National Center for Scientific Research (CNRS), the French National Institute of Health and Medical Research (INSERM), the French Alternative Energies and Atomic Energy Commission (CEA), Inventors for the Digital World (INRIA), and the French National Institute for Agricultural Research (INRA).
• Nearly 200 businesses and 400 jobs, or 50% of France’s biotechnology businesses are based in the Ile-de-France
• 57% of French pharmaceutical companies, equating to 324 businesses and 32,257 jobs in the pharmaceutical industry
• 360 businesses, accounting for 10,500 jobs in medical technology
• Nine universities and 20 graduate schools
• Europe’s largest hospital network
• World leaders in biotechnology, medical technology and the pharmaceutical industry[1]
Sponsors: EY, Expert Lead, Crescentia consulting, Granrut, La Simple Agence, Biblioteque nationale de France (BnF)
About the Seine-Saint-Denis CCI
The Seine-Saint-Denis Chamber of Commerce and Industry provides support to businesses right from inception and throughout their growth. It has been a BIOCITECH partner since 2012 and provides services tailored to the complex’s resident businesses: individual consultancy on commercial strategy, international expansion, partnerships and funding, and leadership of the ‘NetBiotech’ network.
In parallel, it provides business intelligence and services to promote the site, supporting the initiatives undertaken by the complex.
About Medicen Paris Region
Founded in 2005, the Medicen Paris Region global competitiveness cluster aims to position the Paris Region as a European industrial leader in diagnostic and therapeutic innovation and leading-edge health technologies, thus enabling it to become one of the global centres for translational medicine. Medicen Paris Region's partnership approach is based on the concept of economic value creation in the Paris Region stimulated by innovation, which forms the very basis of the creation of competitiveness clusters and sets three main priorities:
• Developing growth and employment in profitable markets in a successful dynamic relationship between YICs/SMEs, large firms and academic laboratories, clinical centres and educational establishments, promoting transfer of innovative technologies
• Strengthening international competitiveness for the French "health and leading-edge health technology" sector promoting those involved and stimulating the Paris Region's capacity for innovation
• Helping to increase the attractiveness of the Paris Region and the vitality of its healthcare sector For more information: www.medicen.org
About Biocitech
BIOCITECH is a city complex for healthcare and biotechnology companies. Located at the edge of Paris, Biocitech fosters business innovation and growth (plug&grow) and provides a complete range of services to residents from inception through to business maturity (plug&live).
BIOCITECH's package includes real estate services, scientific services, technical services and communal services that support entrepreneurial development. BIOCITECH is ICPE certified (Equipment Certified to Protect the Environment) and provides entrepreneurs with secure premises of a high technological standard.
BIOCITECH generates strong synergies and numerous collaborations for resident firms that are at the forefront of innovation. BIOCITECH is a key element in the Medicen Paris region’s world-class competitiveness hub for health and new therapies and also belongs to the Cap Digital and Systematic clusters.
Help employers find you! Check out all the jobs and post your resume.
The winning businesses in the pitching competition are PHYCOPHARMA, KALLISTEM and HPE INGREDIENTS
Romainville, France, June 26, 2015 – BIOCITECH, the city complex for healthcare and biotechnology businesses and the Seine-Saint-Denis Chamber of Commerce and Industry (CCI), today announce the three winners of the first BIOCITECH Funding Day. Taking place in BIOCITECH’s fully refurbished auditorium, this one-day event for start-ups and SMEs in the healthcare and biotechnology sector is a chance for entrepreneurs, leading players in funding and sector experts to engage in discussion and debate.
The winners of the pitching competition were announced during the evening and prizes were awarded by the Bibliothèque nationale de France (BnF), Crescentia consulting, EY, Granrut and La Simple Agence. To begin with, 25 of the businesses that registered on the website were selected to make a poster presentation of their business to investors. Nine of them were given the opportunity to pitch at a plenary session. To conclude the day, a panel made up of members from each round-table session selected three winners:
• Phycopharma: development prize, creates drug candidates based on microalgae for the treatment of resistant tumors
• Kallistem: seed-funding prize, develops innovative cell culture technology in reproductive biology
• HPE Ingredients: emergence prize, aims to develop nutrition and heath ingredients from food processing of snails.
The winners will benefit from:
• Project evaluations carried out by Ernst & Young
• Legal counsel (corporate, social and fiscal law, IP-IT) by Granrut
• Business development consulting by Crescentia
• Communication advice with La Simple Agence
• Free access to and use of a prestigious room at the BnF for a business event
Organized by BIOCITECH and the Seine-Saint-Denis CCI, the event aims to clarify the expectations of businesses from financial backers and vice versa, ensuring a shared understanding of the keys to funding. It also provides insight into the funding hurdles that healthcare and biotechnology businesses can face at every stage of their lifecycle, including:
• Funding for the growth of mature businesses
• Funding for initial phases of development
• Seed funding
The inaugural event featured speeches from political figures such as Claude Bartolone and from players in innovation and funding for innovation, such as Christian Lajoux, chairman of the Medicen Paris Region healthcare competitiveness cluster. There were also presentations from BIOCITECH resident companies, including Galapagos and Pherecydes Pharma; on their experience of funding, from fundraising to crowdfunding and stock market listing.
“Businesses in the healthcare and biotechnology sector offer a rich seam of growth and employment opportunities. Biocitech residents are no exception,” said Pierre-Antoine Gailly, chairman of the CCI for the Paris-Ile-de-France region. “Many of them need access to significant ongoing funding, in view of the high levels of risk and the lengthy development time associated with the sector. These businesses now have to muster considerable energy and resources for their fundraising to be successful. This event gives them the chance to meet a large number of potential investors in just one day.”
“We are very pleased with the success of this first BIOCITECH Funding Day, organized jointly with our partner, the CCI for Seine-Saint-Denis. The event was a tremendous opportunity for our resident businesses and for the other businesses present to meet and engage in dialogue with the leading players in funding. Dialogue and round-table discussions focused on the keys to successful fundraising and the secrets of funding for growth,” said Jean-François Boussard, chairman of BIOCITECH. “We will continue to organize this kind of event at the BIOCITECH city complex as it fits perfectly with our purpose; supporting our residents in their development and growth. Please join the discussion on the blog. I look forward to seeing you next year, for the second BIOCITECH Funding Day.”
“I wanted to take part in this first BIOCITECH Funding Day as the new chairman of Medicen, since we are working to enhance the appeal of the Ile-de-France region and the vitality of the healthcare sector, reflecting the vitality of the BIOCITECH city complex. This kind of event helps to provide players in the healthcare sector with the keys to funding and gives them access to expert advice to accelerate their development,” added Christian Lajoux, chairman of Medicen Paris Region.
In the life sciences sector, the Ile-de-France has a concentration of 300 public and private sector research laboratories, 11,800 researchers, including 4,400 in industry, and prestigious, world-renowned organizations such as the Institut Pasteur, the Institut Curie, the Institut Gustave Roussy, the French National Center for Scientific Research (CNRS), the French National Institute of Health and Medical Research (INSERM), the French Alternative Energies and Atomic Energy Commission (CEA), Inventors for the Digital World (INRIA), and the French National Institute for Agricultural Research (INRA).
• Nearly 200 businesses and 400 jobs, or 50% of France’s biotechnology businesses are based in the Ile-de-France
• 57% of French pharmaceutical companies, equating to 324 businesses and 32,257 jobs in the pharmaceutical industry
• 360 businesses, accounting for 10,500 jobs in medical technology
• Nine universities and 20 graduate schools
• Europe’s largest hospital network
• World leaders in biotechnology, medical technology and the pharmaceutical industry[1]
Sponsors: EY, Expert Lead, Crescentia consulting, Granrut, La Simple Agence, Biblioteque nationale de France (BnF)
About the Seine-Saint-Denis CCI
The Seine-Saint-Denis Chamber of Commerce and Industry provides support to businesses right from inception and throughout their growth. It has been a BIOCITECH partner since 2012 and provides services tailored to the complex’s resident businesses: individual consultancy on commercial strategy, international expansion, partnerships and funding, and leadership of the ‘NetBiotech’ network.
In parallel, it provides business intelligence and services to promote the site, supporting the initiatives undertaken by the complex.
About Medicen Paris Region
Founded in 2005, the Medicen Paris Region global competitiveness cluster aims to position the Paris Region as a European industrial leader in diagnostic and therapeutic innovation and leading-edge health technologies, thus enabling it to become one of the global centres for translational medicine. Medicen Paris Region's partnership approach is based on the concept of economic value creation in the Paris Region stimulated by innovation, which forms the very basis of the creation of competitiveness clusters and sets three main priorities:
• Developing growth and employment in profitable markets in a successful dynamic relationship between YICs/SMEs, large firms and academic laboratories, clinical centres and educational establishments, promoting transfer of innovative technologies
• Strengthening international competitiveness for the French "health and leading-edge health technology" sector promoting those involved and stimulating the Paris Region's capacity for innovation
• Helping to increase the attractiveness of the Paris Region and the vitality of its healthcare sector For more information: www.medicen.org
About Biocitech
BIOCITECH is a city complex for healthcare and biotechnology companies. Located at the edge of Paris, Biocitech fosters business innovation and growth (plug&grow) and provides a complete range of services to residents from inception through to business maturity (plug&live).
BIOCITECH's package includes real estate services, scientific services, technical services and communal services that support entrepreneurial development. BIOCITECH is ICPE certified (Equipment Certified to Protect the Environment) and provides entrepreneurs with secure premises of a high technological standard.
BIOCITECH generates strong synergies and numerous collaborations for resident firms that are at the forefront of innovation. BIOCITECH is a key element in the Medicen Paris region’s world-class competitiveness hub for health and new therapies and also belongs to the Cap Digital and Systematic clusters.
Help employers find you! Check out all the jobs and post your resume.